Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Novartis AG (NVS)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
OPERATING METRICS
REVENUE SOURCES
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for NVS as compared to
Top Competitors
Drug Manufacturers - Major
Drug Manufacturers
Drugs - Generic
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Revenue
►
42.0B
HIGH
R&D Expense
►
7.22B
AVG
R&D/Sales Ratio
►
17.4%
AVG
Number of Drug Approvals
►
2.00
AVG
Number of Drugs in Phase I
►
1.00
VERY LOW
Number of Drugs in Phase II
►
22.0
AVG
Number of Drugs in Phase III
►
13.0
AVG
New Drug Applications
Number of Drug Approvals
Number of Drugs in Phase I
Number of Drugs in Phase II
Number of Drugs in Phase III
R&D/Sales Ratio
Research and Development Expense
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
42.0B
HIGH
EBITDA
►
11.8B
AVG
Net Income
►
7.63B
AVG
Revenue Growth
►
5%
AVG
Net Income Growth
►
-38.1%
AVG
Operating Margin
►
23.3%
AVG
Net Margin
►
18%
AVG
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.669
AVG
Current Ratio
►
1.77
AVG
Quick Ratio
►
1.37
AVG
Interest Coverage Ratio
►
23.6
AVG
Book Value Per Share
►
22.6
Cash Per Share
►
5.30
Loading...
STOCK SUMMARY
Open
53.25
Day Range
53.44
-
53.94
52 Week Range
33.34
-
54.23
Volume
1.61M
Avg Volume (3 mo)
1.29M
Shares Outstanding
2.29B
Market Cap
122B
VALUATION
Price to Earnings (P/E)
►
13.5
AVG
Price to Book (P/B)
►
2.03
AVG
Price to Sales (P/S)
►
2.44
AVG
Return on Assets (ROA)
►
9.6%
AVG
Return on Equity (ROE)
►
15%
AVG
EV/EBITDA
►
10.5
AVG
Dividend Yield
3.7%
HIGH
ANALYST RECOMMENDATIONS
OWNERSHIP
Held by institutions
9.7%